đź’¨ Abstract
Chai Discovery, a biotech startup backed by OpenAI, has raised $130 million in a Series B round, valuing the company at $1.3 billion. Led by General Catalyst and Oak HC/FT, the funding round includes contributions from Menlo Ventures, OpenAI, and new investors like Glade Brook and Emerson Collective. Chai Discovery aims to accelerate drug development using AI, specifically focusing on predicting interactions between biochemical molecules.
Courtesy: Lucas Ropek
Suggested
Nvidia bulks up open source offerings with an acquisition and new open AI modelsÂ
Lightspeed raises record $9B in fresh capital
Disney hits Google with cease-and-desist claiming 'massive' copyright infringement
Epic Games' Fortnite is back in US Google Play Store, as court partially reverses restrictions it won on iOS
The market has 'switched' and founders have the power now, VCs say
1X struck a deal to send its 'home' humanoids to factories and warehouses
Google launched its deepest AI research agent yet — on the same day OpenAI dropped GPT-5.2
Stanford's star reporter takes on Silicon Valley's 'money-soaked' startup culture
State attorneys general warn Microsoft, OpenAI, Google, and other AI giants to fix 'delusional' outputs